Glucocorticoid receptor antagonist

This page covers all Glucocorticoid receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glucocorticoid receptor (GR), Glucocorticoid receptor.

Targets

Glucocorticoid receptor (GR) · Glucocorticoid receptor

Marketed (1)

• Placebo-matching Mifepristone · Roger K. Pitman, MD · Psychiatry / Neurology
  Mifepristone is a glucocorticoid receptor antagonist that blocks cortisol signaling to modulate stress-related memory and emotional processing.

Phase 2 pipeline (1)

• Dex 21-P · Quince Therapeutics S.p.A. · Rheumatology
  Dex 21-P is a glucocorticoid receptor antagonist.

Patent intelligence

• glucocorticoid receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates